Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Target Hemoglobin May Be Achieved with Intravenous Iron Alone in Anemic Patients with Cardiorenal Syndrome: An Observational Study.

Ben-Assa E, Shacham Y, Shashar M, Leshem-Rubinow E, Gal-Oz A, Schwartz IF, Schwartz D, Silverberg DS, Chernin G.

Cardiorenal Med. 2015 Oct;5(4):246-53. doi: 10.1159/000433564. Epub 2015 Jul 4.

2.

Is Correction of Iron Deficiency a New Addition to the Treatment of the Heart Failure?

Silverberg DS, Wexler D, Schwartz D.

Int J Mol Sci. 2015 Jun 18;16(6):14056-74. doi: 10.3390/ijms160614056. Review.

3.

Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron.

Silverberg DS, Mor R, Weu MT, Schwartz D, Schwartz IF, Chernin G.

BMC Pulm Med. 2014 Feb 24;14:24. doi: 10.1186/1471-2466-14-24.

4.

Darbepoetin alfa in systolic heart failure.

Silverberg DS, Schwartz D, Wexler D.

N Engl J Med. 2013 Aug 1;369(5):487-8. doi: 10.1056/NEJMc1306321. No abstract available.

PMID:
23902506
5.

The missed opportunities to diagnose and treat iron deficiency in patients hospitalized with heart failure.

Silverberg DS, Schwartz D, Schwartz I, Ben Assa E.

Int J Cardiol. 2013 Oct 3;168(3):2164-6. doi: 10.1016/j.ijcard.2013.01.249. Epub 2013 Feb 28.

PMID:
23453867
6.

Avoiding early dialysis for severe fluid retention in heart failure.

Silverberg DS, Wexler D.

Rev Esp Cardiol (Engl Ed). 2012 Nov;65(11):975-6. doi: 10.1016/j.recesp.2012.05.016. Epub 2012 Aug 25. English, Spanish. No abstract available.

PMID:
22925470
7.

The role of iron, omega-3 Fatty acids, and vitamins in heart failure.

Silverberg DS, Schwartz D.

Curr Treat Options Cardiovasc Med. 2012 Aug;14(4):328-41. doi: 10.1007/s11936-012-0188-3.

PMID:
22644351
8.

Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy.

Chernin G, Gal-Oz A, Ben-Assa E, Schwartz IF, Weinstein T, Schwartz D, Silverberg DS.

Clin Cardiol. 2012 Jan;35(1):32-6. doi: 10.1002/clc.20987. Epub 2011 Nov 6.

9.

Correction of iron deficiency in the cardiorenal syndrome.

Silverberg DS, Wexler D, Iaina A, Schwartz D.

Int J Nephrol. 2011;2011:365301. doi: 10.4061/2011/365301. Epub 2011 Apr 19.

10.

Intravenous iron in heart failure: beyond targeting anemia.

Silverberg DS, Iaina A, Schwartz D, Wexler D.

Curr Heart Fail Rep. 2011 Mar;8(1):14-21. doi: 10.1007/s11897-010-0034-4. Review.

PMID:
21057903
11.

The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome.

Silverberg DS.

Heart Fail Rev. 2011 Nov;16(6):609-14. doi: 10.1007/s10741-010-9194-2. Review.

PMID:
20865450
12.

Anaemia management in cardio renal disease.

Silverberg DS, Wexler D, Iaina A, Schwartz D.

J Ren Care. 2010 May;36 Suppl 1:86-96. doi: 10.1111/j.1755-6686.2010.00164.x. Review.

PMID:
20586904
13.

Severe obstructive sleep apnea: sleepy versus nonsleepy patients.

Oksenberg A, Arons E, Nasser K, Shneor O, Radwan H, Silverberg DS.

Laryngoscope. 2010 Mar;120(3):643-8. doi: 10.1002/lary.20758.

PMID:
19941283
14.

The anemia of heart failure.

Silverberg DS, Wexler D, Palazzuoli A, Iaina A, Schwartz D.

Acta Haematol. 2009;122(2-3):109-19. doi: 10.1159/000243795. Epub 2009 Nov 10.

PMID:
19907148
15.

Avoiding the supine posture during sleep for patients with mild obstructive sleep apnea.

Oksenberg A, Silverberg DS.

Am J Respir Crit Care Med. 2009 Jul 1;180(1):101; author reply 101-2. No abstract available.

PMID:
19535668
16.

Immunological mechanisms of pentoxifylline in chronic heart failure.

Silverberg DS, Wexler D, Iaina A, Schwartz D.

Eur J Heart Fail. 2009 Jul;11(7):728. doi: 10.1093/eurjhf/hfp067. Epub 2009 May 20. No abstract available.

17.

Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.

Palazzuoli A, Silverberg DS, Calabrò A, Spinelli T, Quatrini I, Campagna MS, Franci B, Nuti R.

J Cardiovasc Pharmacol. 2009 Jun;53(6):462-7. doi: 10.1097/FJC.0b013e3181a6ac38.

PMID:
19455052
18.

Restless legs syndrome (RLS) in anemic patients with congestive heart failure and chronic renal failure: lack of effect of anemia treatment.

Zilberman M, Silverberg DS, Schwartz D, Oksenberg A.

Int J Cardiol. 2010 Aug 20;143(2):205-7. doi: 10.1016/j.ijcard.2008.11.177. Epub 2009 Jan 7.

PMID:
19131126
19.

The cardio-renal anemia syndrome.

Iaina A, Silverberg DS, Wexler D, Iaina Nomy L.

Med Pregl. 2007;60 Suppl 2:145-50. Review.

PMID:
18928182
20.

The role of correction of anaemia in patients with congestive heart failure: a short review.

Silverberg DS, Wexler D, Iaina A, Schwartz D.

Eur J Heart Fail. 2008 Sep;10(9):819-23. doi: 10.1016/j.ejheart.2008.06.015. Epub 2008 Aug 15. Review.

21.

The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions.

Silverberg DS, Wexler D, Iaina A, Schwartz D.

Clin Exp Nephrol. 2009 Apr;13(2):101-106. doi: 10.1007/s10157-008-0074-1. Epub 2008 Aug 1. Review.

PMID:
18670732
23.

Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome.

Palazzuoli A, Gallotta M, Iovine F, Nuti R, Silverberg DS.

Int J Clin Pract. 2008 Feb;62(2):281-6. Epub 2007 Dec 11. Review.

PMID:
18081797
24.

Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.

Zilberman M, Silverberg DS, Bits I, Steinbruch S, Wexler D, Sheps D, Schwartz D, Oksenberg A.

Am Heart J. 2007 Nov;154(5):870-6. Epub 2007 Sep 14.

PMID:
17967592
25.

Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome.

Palazzuoli A, Silverberg DS, Iovine F, Calabrò A, Campagna MS, Gallotta M, Nuti R.

Am Heart J. 2007 Oct;154(4):645.e9-15.

PMID:
17892986
26.

The interaction between heart failure and other heart diseases, renal failure, and anemia.

Silverberg DS, Wexler D, Iaina A, Schwartz D.

Semin Nephrol. 2006 Jul;26(4):296-306. Review.

PMID:
16949468
27.

Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists.

Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D.

Int Urol Nephrol. 2006;38(2):295-310. Review.

PMID:
16868702
28.

Erythropoietin in heart failure.

Silverberg DS, Wexler D, Blum M, Iaina A, Sheps D, Keren G, Schwartz D.

Semin Nephrol. 2005 Nov;25(6):397-403. Review.

PMID:
16298262
29.

Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.

Iaina A, Silverberg DS, Wexler D.

Nat Clin Pract Cardiovasc Med. 2005 Feb;2(2):95-100. Review.

PMID:
16265380
30.

The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?

Silverberg DS, Wexler D, Iaina A.

J Nephrol. 2004 Nov-Dec;17(6):749-61. Review.

PMID:
15593047
31.

Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure.

Silverberg DS, Wexler D, Blum M, Iaina A, Sheps D, Keren G, Scherhag A, Schwartz D.

Kidney Blood Press Res. 2005;28(1):41-7. Epub 2004 Oct 15.

32.

The role of anemia in congestive heart failure and chronic kidney insufficiency: the cardio renal anemia syndrome.

Silverberg DS, Wexler D, Iaina A.

Perspect Biol Med. 2004 Autumn;47(4):575-89.

PMID:
15467179
33.

The effect of body posture on sleep-related breathing disorders: facts and therapeutic implications.

Oksenberg A, Silverberg DS.

Sleep Med Rev. 1998 Aug;2(3):139-62.

PMID:
15310498
34.

The interaction between heart failure, renal failure and anemia - the cardio-renal anemia syndrome.

Silverberg DS, Wexler D, Blum M, Wollman Y, Schwartz D, Sheps D, Keren G, Iaina A.

Blood Purif. 2004;22(3):277-84. Epub 2004 May 27. Review.

PMID:
15166489
35.

Correction of anemia in patients with congestive heart failure increases resting energy expenditure.

Vaisman N, Silverberg DS, Wexler D, Niv E, Blum M, Keren G, Soroka N, Iaina A.

Clin Nutr. 2004 Jun;23(3):355-61.

PMID:
15158299
36.

Erythropoietin should be part of congestive heart failure management.

Silverberg DS, Wexler D, Blum M, Schwartz D, Wollman Y, Iaina A.

Kidney Int Suppl. 2003 Nov;(87):S40-7. Review.

PMID:
14531772
37.
38.

Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians.

Silverberg DS, Wexler D, Blum M, Schwartz D, Keren G, Sheps D, Iaina A.

Isr Med Assoc J. 2003 May;5(5):337-9.

39.

Anemia in chronic kidney disease and congestive heart failure.

Silverberg DS, Wexler D, Blum B, Iaina A.

Blood Purif. 2003;21(1):124-30. Review.

PMID:
12596758
40.

The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron.

Silverberg DS, Wexler D, Blum M, Tchebiner JZ, Sheps D, Keren G, Schwartz D, Baruch R, Yachnin T, Shaked M, Schwartz I, Steinbruch S, Iaina A.

Nephrol Dial Transplant. 2003 Jan;18(1):141-6.

PMID:
12480972
41.

The importance of anemia and its correction in the management of severe congestive heart failure.

Silverberg DS, Wexler D, Iaina A.

Eur J Heart Fail. 2002 Dec;4(6):681-6. Review.

42.

The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.

Silverberg DS, Wexler D, Blum M, Tchebiner J, Sheps D, Keren G, Schwartz D, Baruch R, Yachnin T, Shaked M, Zubkov A, Steinbruch S, Iaina A.

Clin Nephrol. 2002 Jul;58 Suppl 1:S37-45.

PMID:
12227725
43.

Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases.

Silverberg DS, Wexler D, Blum M, Sheps D, Schwartz D, Yachnin T, Baruch R, Tchebiner J, Zubkov A, Shaked M, Steinbruch S, Keren G, Iaina A.

Perit Dial Int. 2001;21 Suppl 3:S236-40.

PMID:
11887828
44.

Treating obstructive sleep apnea improves essential hypertension and quality of life.

Silverberg DS, Iaina A, Oksenberg A.

Am Fam Physician. 2002 Jan 15;65(2):229-36. Review.

45.

Apnoea characteristics across the night in severe obstructive sleep apnoea: influence of body posture.

Oksenberg A, Khamaysi I, Silverberg DS.

Eur Respir J. 2001 Aug;18(2):340-6.

46.

The pathological consequences of anaemia.

Silverberg DS, Iaina A, Wexler D, Blum M.

Clin Lab Haematol. 2001 Feb;23(1):1-6. Review.

PMID:
11422223
47.

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, Schwartz D, Yachnin T, Steinbruch S, Shapira I, Laniado S, Iaina A.

J Am Coll Cardiol. 2001 Jun 1;37(7):1775-80.

48.

Are sleep-related breathing disorders important contributing factors to the production of essential hypertension?

Silverberg DS, Oksenberg A.

Curr Hypertens Rep. 2001 Jun;3(3):209-15. Review.

PMID:
11353571
49.

The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.

Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.

Clin Nephrol. 2001 Mar;55(3):212-9.

PMID:
11316241
50.

Association of body position with severity of apneic events in patients with severe nonpositional obstructive sleep apnea.

Oksenberg A, Khamaysi I, Silverberg DS, Tarasiuk A.

Chest. 2000 Oct;118(4):1018-24.

PMID:
11035672

Supplemental Content

Loading ...
Support Center